CIBICI   14215
CENTRO DE INVESTIGACION EN BIOQUIMICA CLINICA E INMUNOLOGIA
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
REGULATION OF MICROGLIAL CELL CYTOKINE PRODUCTION BY TYPE 2 CYTOKINES
Autor/es:
GAVIGLIO, EA; SORIA, JA; ARROYO, DS; IRIBARREN, P
Lugar:
Buenos Aires
Reunión:
Congreso; First French-Argentine Immunology Congress; 2010
Institución organizadora:
Sociedad Argentina de Inmunología
Resumen:
Inflammation plays an important role in central nervous system (CNS) infection and the progression of neurodegenerative diseases. Microglial cells are phagocytic myeloid cells located in the nervous parenchyma playing a key role in the initiation, progression and resolution of neuroinflammation. It is well known that microglial cells play a key role in mediating inflammatory processes in the CNS, which are associated with various neurodegenerative diseases. Given the potential beneficial effects of anti-inflammatory drugs and cytokines on the treatment and prevention of neurodegenerative diseases, we investigated the role of IL-4 and IL-13 in the regulation of cytokine production by microglial cells. First of all, we evaluated the effects of stimulation of mouse microglial cell lines with IL-4, IL-13 or INF-gamma, on the production of TNF alpha, IL-10 and IL-27. Both, IL-4 and IL-13 failed to induce the secretion of TNFalpha or IL-27 (p NS). However, IL-4 induced the secretion of the anti-inflammatory cytokine IL-10. In another set of experiments we tested if IL-4 or IL-13 were capable to inhibit the cytokine production of microglial cells activated by pro-inflammatory molecules, such as lipopolysaccharide (LPS) and INF gamma. We found that IL-4 inhibited the production of IL-6 on LPS-stimulated microglial cells (p